Volume 22, Number 2—February 2016
Dispatch
Louseborne Relapsing Fever among East African Refugees, Italy, 2015
Table
Characteristic | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
---|---|---|---|---|---|
Time from arrival in Italy | 3 d | 4 y | 3 y | 10 d | 10 d |
Age, y | 20 | 27 | 31 | 20 | 26 |
Date of admission | Jun 9 | Jul 28 | Sept 5 | Oct 1 | Sept 29 |
Date of symptom onset |
Jun 7 |
Jul 24 |
Sept 1 |
Sept 27 |
Sept 26 |
Symptom | |||||
Fever | Yes | Yes | Yes | Yes | Yes |
Abdominal pain | No | No | Yes | Yes | No |
Vomiting | Yes | Yes | Yes | Yes | No |
Diarrhea | No | No | Yes | No | No |
Headache | Yes | Yes | Yes | Yes | Yes |
Myalgia | No | Yes | No | No | Yes |
Other |
None |
Lumbar pain |
None |
Cough |
Chest pain, itching |
Laboratory test (reference) | |||||
Platelets (>150,000/μL) | 32,000 | 47,000 | 22,000 | 41,000 | 2,9000 |
Bilirubin (<1.2 mg/dL) | 2.3 | 1.8 | 3.9 | 4.2 | 1.8 |
Liver function† | Normal | Normal | AST ×4; ALT ×3 | AST ×3; ALT normal | Normal |
Prothrombin time (>70%) | 78% | 66% | 68% | 100% | 70% |
CRP† | ×16 | ×56 | ×95 | ×115 | ×59 |
Procalcitonin (<0.5) | 11.36 | NA | 21 | 11.9 | NA |
QTc (<440 msec) | 428 | 361 | 423 | 391 | 414 |
PCR for Borrelia recurrentis |
Positive |
Positive |
Positive |
Positive |
Positive |
Treatment | Doxycicline | Doxycicline | Doxycicline | Doxicicline + ceftriaxone | Doxycicline, switched to ceftriaxone |
Jarisch-Herxheimer reaction | Yes, mild | Not observed | Not observed | Not observed | Yes, moderate |
*ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; NA, not available; QTc, corrected QT interval.
†Indicated as normal (within reference value) or × upper reference value.
Page created: January 15, 2016
Page updated: January 15, 2016
Page reviewed: January 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.